D2C telehealth
Investors have showered the New York company with $876 million to date.
The newly announced deal is expected to close in Q4 2020, and values the direct-to-consumer telehealth company's combined entity at $1.6 billion.
Virtual primary care customers living in specific regions will have the option to use Alto's app and services at no additional cost.